Patent ID: 7858323
Filing Date: 2010-12-28
Classification: C07K,C12N,C12Q,G01N

Abstract:
1. A method of screening for the presence or absence of prostate cancer in a subject, comprising: a) providing a sample from said subject suspected of having prostate cancer; and b) detecting the presence or absence of a humoral response to a tumor antigen selected from one or more of the group consisting of Eukaryotic Translation Initiation Factor 4Gamma 1 (eIF4G 1), Ribosomal Protein L22 (RPL22), Ribosomal Protein L 13A (RPL13A), and protein XP_373908 (SEQ IDNO:402), wherein said detecting comprises detecting the presence of an autoantibody to said tumor antigen; wherein the presence of said humoral response is indicative of the presence of prostate cancer.